144 related articles for article (PubMed ID: 38116795)
1. Management of aggressive variants of papillary thyroid cancer.
Lee YK; Rovira A; Carroll PV; Simo R
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):125-133. PubMed ID: 38116795
[TBL] [Abstract][Full Text] [Related]
2. Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.
Coca-Pelaz A; Shah JP; Hernandez-Prera JC; Ghossein RA; Rodrigo JP; Hartl DM; Olsen KD; Shaha AR; Zafereo M; Suarez C; Nixon IJ; Randolph GW; Mäkitie AA; Kowalski LP; Vander Poorten V; Sanabria A; Guntinas-Lichius O; Simo R; Zbären P; Angelos P; Khafif A; Rinaldo A; Ferlito A
Adv Ther; 2020 Jul; 37(7):3112-3128. PubMed ID: 32488657
[TBL] [Abstract][Full Text] [Related]
3. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
4. Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma.
Cartwright S; Fingeret A
Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):351-357. PubMed ID: 32701516
[TBL] [Abstract][Full Text] [Related]
5. Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
Holoubek SA; MacKinney EC; Khokar AM; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
Surgery; 2022 Jan; 171(1):203-211. PubMed ID: 34384604
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Brain Metastases from Papillary Thyroid Carcinomas:Five Surgical Cases in Our Hospital and a Literature Review].
Fujii T; Takeuchi S; Toyooka T; Otani N; Wada K; Mori K
No Shinkei Geka; 2018 Nov; 46(11):975-982. PubMed ID: 30458434
[TBL] [Abstract][Full Text] [Related]
7. Clinical-Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma.
Poma AM; Macerola E; Proietti A; Vignali P; Sparavelli R; Torregrossa L; Matrone A; Basolo A; Elisei R; Santini F; Ugolini C
Front Endocrinol (Lausanne); 2022; 13():842424. PubMed ID: 35311230
[TBL] [Abstract][Full Text] [Related]
8. Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.
Kuo EJ; Goffredo P; Sosa JA; Roman SA
Thyroid; 2013 Oct; 23(10):1305-11. PubMed ID: 23600998
[TBL] [Abstract][Full Text] [Related]
9. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
10. Contemporary management of papillary carcinoma of the thyroid gland.
Rosenbaum MA; McHenry CR
Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
[TBL] [Abstract][Full Text] [Related]
11. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
12. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
13. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
14. Management of the Patient with Aggressive and Resistant Papillary Thyroid Carcinoma.
Miftari R; Topçiu V; Nura A; Haxhibeqiri V
Med Arch; 2016 Jul; 70(4):314-317. PubMed ID: 27703298
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.
Roti E; Rossi R; Trasforini G; Bertelli F; Ambrosio MR; Busutti L; Pearce EN; Braverman LE; Degli Uberti EC
J Clin Endocrinol Metab; 2006 Jun; 91(6):2171-8. PubMed ID: 16478817
[TBL] [Abstract][Full Text] [Related]
16. Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.
Lubitz CC; De Gregorio L; Fingeret AL; Economopoulos KP; Termezawi D; Hassan M; Parangi S; Stephen AE; Halpern EF; Donelan K; Swan JS
Thyroid; 2017 Feb; 27(2):197-206. PubMed ID: 27824301
[TBL] [Abstract][Full Text] [Related]
17. [Differentiated thyroid cancer in childhood].
Leboulleux S; Hartl D; Baudin E; Schlumberger M
Bull Cancer; 2012 Nov; 99(11):1093-9. PubMed ID: 23149302
[TBL] [Abstract][Full Text] [Related]
18. Papillary thyroid cancer.
Sosa JA; Udelsman R
Surg Oncol Clin N Am; 2006 Jul; 15(3):585-601. PubMed ID: 16882499
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
Xu B; Tallini G; Scognamiglio T; Roman BR; Tuttle RM; Ghossein RA
Thyroid; 2017 Apr; 27(4):512-517. PubMed ID: 28136139
[TBL] [Abstract][Full Text] [Related]
20. Remarkable response to radioiodine therapy in a case of metastatic macrofollicular variant of papillary thyroid carcinoma.
Marques P; Leite V; Bugalho MJ
Clin Nucl Med; 2014 Feb; 39(2):219-21. PubMed ID: 24368535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]